SM
Shweta Maniar

Shweta Maniar insider trades: RxSight (RXST) stock sales

RxSight Last trade Jan 22, 2025 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2022
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Shweta reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 22, 2025RXST↓ Sell$109K
Nov 26, 2024RXST↓ Sell$174K
Jan 18, 2024RXST↓ Sell$293K
Jan 8, 2024RXST↓ Sell$289K
Aug 29, 2023RXST↓ Sell$120K
Mar 10, 2023OFIX↓ Sell$76K
Dec 29, 2022SPNE↓ Sell10b5-1$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RXST insiders

Open-market trades in the last 12 months

About Shweta Maniar's insider trades

Shweta Maniar is an insider at RxSight (RXST). Since Dec 29, 2022, Shweta has reported no open-market purchases and 7 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (13 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RXST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.